publication venue for
- EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS FROM A LONGITUDINAL OBSERVATIONAL REGISTRY 2019
- Axial Spondyloarthritis: Does Magnetic Resonance Imaging Classification Improve Report Interpretation. 30:145-150. 2024
- Risk Factors and Clinical Outcomes Associated With Sarcopenia in Rheumatoid Arthritis. 30:18-25. 2024
- Mind the Gap. 29:235-239. 2023
- Arthroscopic Treatment of Synovial Lipomatosis of the Hip, With Concurrent Femoroacetabular Impingement. 27:e591-e595. 2021
- Planning for the Rheumatologist Workforce. 25:142-146. 2019
- Ultrasound-Guided Interventions in Lateral Epicondylitis. 25:e27-e34. 2019
- Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. 24:393-395. 2018
- Attitudes Toward and Management of Fibromyalgia. 24:243-249. 2018
- Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis. 24:93-94. 2018
- Multiorgan Failure From Cryoglobulinemic Vasculitis Following Intravenous Immunoglobulin Replacement Therapy. 22:441-443. 2016
- Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus. 22:287-288. 2016
- Anti-RNA Polymerase III Antibodies in the Diagnosis of Scleroderma Renal Crisis in the Absence of Skin Disease. 20:379-382. 2014
- Fatal Refractory Thrombotic Thrombocytopenic Purpura Complicating Systemic Lupus Erythematosus. 19:412-414. 2013
- Inferior Gluteal Vein Varicosities. 15:387-388. 2009
- Prevention, Diagnosis, and Treatment of Glucocorticoid Induced Osteoporosis by Rheumatologists in a Latin-American City. 14:153-155. 2008
- Image-Guided Corticosteroid Injection of Calcific Tendonitis of Gluteus Maximus. 12:176-178. 2006
- Coexisting Systemic Lupus Erythematosus and Sickle Cell Disease. 11:86-92. 2005
- Incidence of Nonvertebral Fractures in Relation to Time on Treatment and Bone Density in Glucocorticoid-Treated Patients. 9:170-175. 2003
- Improved Gastrointestinal Tolerance and Patient Preference of Enteric-Coated Sulfasalazine Versus Uncoated Sulfasalazine Tablets in Patients with Rheumatoid Arthritis. 5:193-200. 1999
- Immune Thrombocytopenic Purpura. 3:95-101. 1997